Feeds:
Posts
Comments

Posts Tagged ‘New York Times’

After President Trump fired widely respected Preet Bharara as the US Attorney for the Southern District of New York, he then personally interviewed candidates and selected Geoffrey Berman.

US Attorney for Southern District of New York, Past and Current

Screen Shot 2018-04-18 at 10.27.54 AM.png      Screen Shot 2018-04-18 at 10.28.17 AM.png

Preet Bharara              Geoffrey Berman

Geoffrey Berman then made two major decisions, the first was to recuse himself from the Michael Cohen investigation and the second was to hire Robert Khuzami from Kirkland Ellis, who by default now leads the investigation.

Berman clearly knew there were major legal issues coming regarding Trump and Cohen and the question has to be asked, was Khuzami installed by Berman to be Trump’s “fixer?”

Screen Shot 2018-04-18 at 10.55.37 AM.png        Screen Shot 2018-04-16 at 4.18.22 PM.png

Michael Cohen                Robert Khuzami

(more…)

Read Full Post »

    Senator McConnell’s Dilemma:   To Serve Patients or Investors?

Screen Shot 2017-07-18 at 3.02.20 PM

When evaluating health care investments it is important to analyze the structure of leading drug and medical equipment companies.  A close look indeed reveals a derivative driven system in which private equity and hedge funds increase demand for drug payments by purchasing the rights to the cash flows from key drugs.  Patients are indeed unaware that many of the drugs they consume are now owned in part by private equity investors.

(more…)

Read Full Post »

Disclsoure and Media Development Background:  Parish & Company maintains no speculative investments in the health care companies discussed and does not collaborate with any private equity or hedge funds.  It’s goal is to identify high quality health care opportunities suitable for long term oriented investment.

This effort includes providing high quality news material to leading journalists including Gretchen Morgenson of the NY Times, Mark Maremont and Rich Rubin of the Wall Street Journal, Joseph Tanfani of the LA Times and Margaret Collins of Bloomberg.

In doing its research Parish & Company has revealed a massive price fixing scheme, both in medications and medical equipment, being orchestrated by private equity and hedge funds, often financed by public pensions including Oregon PERS.   These firms purchase drug and medical equipment royalty cash flows and, in conjunction with the use of various drug and medical procedure distribution systems, including hospitals, specialized clinics and pharmacies, are price gouging patients and fleecing taxpayers via Medicare and Medicaid reimbursements.

(more…)

Read Full Post »